We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites at no additional cost to you.
Unlike different industries, the biotech sector hardly slowed throughout the coronavirus pandemic. The newest annual report from Johns Hopkins Technology Ventures (JHTV) touted native development in a bounce-back yr. The write-up, launched earlier this month, pointed to main acquisitions, analysis partnerships, and tons of of innovations.
“Fiscal Year 2021 was a rare one for Johns Hopkins Technology Ventures regardless of the challenges of the pandemic,” Executive Director Christy Wyskiel advised BioBuzz in an e-mail. “We took full benefit of the momentum from the previous couple of years.”
The innovation group painted Baltimore as a booming know-how hub, mentioning that 99% of town’s life sciences actual property is occupied. These corporations are rising.
This January, Exact Sciences finalized its $2.2 billion buy of Thrive Earlier Detection, a company-sponsored by Johns Hopkins Technology Ventures. Wyskiel referred to as it “the most important acquisition of a JHU firm thus far.” Thrive Earlier Detection drew consideration final summer season after elevating $257 million to fund a liquid biopsy take a look at that checks for most cancers.
Hopkins additionally introduced an extension of its analysis partnership with Bayer AG, a German pharmaceutical enterprise. The duo renewed the deal in May, and it lasts via 2024. The alliance will fund potential remedies from the Johns Hopkins Wilmer Eye Institute.
Though Hopkins made splashes with giant contracts, the group moreover developed budding concepts into tangible merchandise.
Hopkins’ remote-controlled ventilators loved a highlight on NBC Nightly News. ClearMask bought 12.5 million clear face coverings. And emocha Health created a cell software to assist staff safely return to work.
“JHTV helped emocha get off the bottom in 2014 and continues to be one in all our greatest champions as we develop,” emocha CEO Sebastian Seiguer advised BioBuzz in a separate e-mail, noting that his group made strides in bronchial asthma, cardiac, diabetes, and tuberculosis remedies. “This yr’s annual report as soon as once more demonstrates JHTV’s influence on innovation and entrepreneurship at Johns Hopkins and in Baltimore and past.”
Breakthroughs additionally included work from Hopkins college students. The Baltimore college runs an entrepreneurial pupil hub referred to as FastForward U. Nearly $30 million of fundraising supported 123 pupil initiatives over the past fiscal yr, which ran from July 1, 2020 to June 30, 2021.
One of those tasks hopes to make vogue extra sustainable. The start-up, Mo. Na. Gems, needs to exchange plastic equipment with biodegradable jewellery. That concept gained the highest prize at this April’s Fuel Demo Day, a contest the place student-run corporations compete for investments.
Altogether, 40 college students served as fellows for the Commercialization Academy at Johns Hopkins Technology Ventures. These fellows scored jobs at AstraZeneca, Bloomberg, and the U.S. Food and Drug Administration.
“JHTV supplied the publicity and experiences I wanted to make knowledgeable choices concerning the course to take my research and profession,” said fellow Samiksha Ramesh, who’s now a biomedical engineering technical advisor for Ropes & Gray LLP.
The Social Innovation Lab at Johns Hopkins Technology Ventures produced comparable success. The lab ran a five-month accelerator for 10 mission-driven groups.
Winifred A. Winston of Dyslexia Advocation Inc. gained the lab’s $25,000 Cohort Prize. Her nonprofit educates and empowers locals with dyslexia and their households.
Another $10,000 went to Sridevi V. Sarma, an affiliate professor within the Department of Biomedical Engineering. Sarma earned the cash on the Pitch It On! competitors for feminine inventors within the AccelHERator effort. She pitched EZTrack, a mind warmth map that helps docs spot the supply of seizures in drug-resistant epilepsy sufferers.
Innovations like these helped Hopkins land 144 licensing agreements price a mixed $38.9 million in fiscal yr 2021. That’s not counting the $768 million in enterprise funding from 30 start-ups or the $496 million in public fairness choices.
Altogether, the JHTV group generated 444 innovations and 166 new U.S. patents.
“Baltimore continues to be an excellent place to start out and develop a scalable, tech-centered enterprise,” added Wyskiel, who can be the senior adviser to the president of Johns Hopkins University for innovation and entrepreneurship. “We are honored to assist our pupil and college innovators deliver their concepts to market.”
Click right here to learn the total fiscal yr 2021 annual report from Johns Hopkins Technology Ventures.
BioBuzz is the Only Media and Events Brand Dedicated Solely to the Regional Biotech and Life Sciences Industry